16436 Federal Register / Vol. 80, No. 59 / Friday, March 27, 2015 / Notices 

XII. No Reacquisition 

For a period of five years from the 

date of entry of this Final Judgment, 

Defendants may not apply for or obtain 

any bus stop authorizations for hop-on, 

hop-off bus tours at the locations of the 

divested CitySights Bus Stop 

Authorizations, except that, after May 1, 

2016, if the NYCDOT revokes a bus stop 

authorization currently granted to an 

affiliate of Twin America other than 

City Sights, Defendants may apply for or 

obtain a bus stop authorization at the 

location of a divested CitySights Bus 

Stop Authorization that is at or in close 

proximity to the location of the bus stop 

authorization NYCDOT has revoked. 

Nothing in this Final Judgment shall be 

construed to prohibit Defendants from 

applying for or obtaining from the 

NYCDOT bus stop authorizations at 

locations other than the locations of the 

CitySights Bus Stop Authorizations, nor 

to limit the NYCDOT’s ability to alter or 

amend Defendants’ bus stop 

authorizations. 

XIII. Retention of Jurisdiction 

This Court retains jurisdiction to 

enable any party to this Final Judgment 

to apply to this Court at any time for 

further orders and directions as may be 

necessary or appropriate to carry out or 

construe this Final Judgment, to modify 

any of its provisions, to enforce 

compliance, and to punish violations of 

its provisions. 

XIV. Expiration of Final Judgment 

Unless this Court grants an extension, 

this Final Judgment shall expire ten 

years from the date of its entry, except 

that Sections XI and XII shall expire five 

years from the date of this Final 

Judgment’s entry. 

XV. Public Interest Determination 

Entry of this Final Judgment is in the 

public interest. The parties have 

complied with the requirements of the 

Antitrust Procedures and Penalties Act, 

15 U.S.C. 16, including making copies 

available to the public of this Final 

Judgment, the Competitive Impact 

Statement, and any comments thereon 

and the United States’ responses to 

comments. Based upon the record 

before the Court, which includes the 

Competitive Impact Statement and any 

comments and response to comments 

filed with the Court, entry of this Final 

Judgment is in the public interest. 

Dated: 

lllllllllllllllllllll

lllllllllllllllllllll

Judge Andrew L. Carter, Jr. 

United States District Judge 

[FR Doc. 2015–07055 Filed 3–26–15; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Mylan Pharmaceuticals, 

Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration in 

accordance with 21 CFR 1301.34(a) on 

or before April 27, 2015. Such persons 

may also file a written request for a 

hearing on the application pursuant to 

21 CFR 1301.43 on or before April 27, 

2015. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Request for hearings should be 

sent to: Drug Enforcement 

Administration, Attention: Hearing 

Clerk/LJ, 8701 Morrissette Drive, 

Springfield, Virginia 22152 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Deputy Assistant 

Administrator of the DEA Office of 

Diversion Control (‘‘Deputy Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on October 

13, 2014, Mylan Pharmaceuticals, Inc., 

3711 Collins Ferry Road, Morgantown, 

West Virginia 26505, applied to be 

registered as an importer of the 

following basic classes of controlled 

substances: 

Controlled substance Schedule 

Amphetamine (1100) .................. II 

Controlled substance Schedule 

Lisdexamfetamine (1205) ........... II 

Methylphenidate (1724) .............. II 

Pentobarbital (2270) ................... II 

Oxycodone (9143) ...................... II 

Hydromorphone (9150) .............. II 

Hydrocodone (9193) ................... II 

Levorphanol (9220) .................... II 

Morphine (9300) ......................... II 

Oxymorphone (9652) .................. II 

Remifentanil (9739) .................... II 

Fentanyl (9801) .......................... II 

The company plans to import the 

listed controlled substances in finished 

dosage form (FDF) from foreign sources 

for analytical testing and clinical trials 

in which the foreign FDF will be 

compared to the company’s own 

domestically-manufactured FDF. This 

analysis is required to allow the 

company to export domesticallymanufactured FDF to foreign markets. 

Dated: March 20, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–06967 Filed 3–26–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1140–0031] 

Agency Information Collection 

Activities: Proposed eCollection 

eComments Requested; Records of 

Acquisition and Disposition, 

Registered Importers of Arms, 

Ammunition, and Implements of War 

on the U.S. Munitions Imports List 

AGENCY: Bureau of Alcohol, Tobacco, 

Firearms and Explosives, Department of 

Justice. 

ACTION: 30-day notice. 

SUMMARY: The Department of Justice 

(DOJ), Bureau of Alcohol, Tobacco, 

Firearms and Explosives (ATF) will 

submit the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

This proposed information collection 

was previously published in the Federal 

Register Volume 80, Number 14, page 

3252 on January 22, 2015, allowing for 

a 60 day comment period. 

DATES: The purpose of this notice is to 

allow for an additional 30 days for 

public comment until April 27, 2015. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments, especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

mstockstill on DSK4VPTVN1PROD with NOTICES